Opko Health completes $31 million private placement
Opko Health has completed a $31 million private placement with seven accredited investors, the company announced.
Osta Biotechnologies Inc. is pleased to announce that on April 1, 2010, it has closed its previously announced ``bought deal'' private placement of 8,400,000 units at a price of $0.06 per unit, for gross proceeds to Osta of $504,000.